Sphingomyelinases in Human Tissues. II. Absence of a Specific Enzyme from Liver and Brain of Niemann-Pick Disease, Type C

Extract: Sphingomyelinase was obtained in excellent yield from liver and brain by homogenization with 0.05 M citrate-phosphate buffer, pH 4.5, containing 0.25% Triton X-100 (v/v) followed by dialysis of the supernatant fluids against 1% glycine. Total recovery of enzyme was slightly less with tissue from Niemann-Pick disease compared with control tissue.Isoelectric focusing of liver and brain extracts was successfully used to resolve several species of sphingomyelinase. Three (I-III) of the five species were partially characterized. Enzyme I (pI 4.6) had a pH optimum of 4.8-5.0 in acetate buffer and a Km value of 0.026 mM. Both sphingomyelinases I and II were the major enzymes, whereas III, IV, and V were found at lower levels. Of the two major species in normal liver and brain (I and II), species I alone persisted in liver from the two cases of type C, while species III, IV, and V were present. In brain, only species II was decreased but the resolution of the brain enzymes was less satisfactory.Speculation: Sphingomyelinases exist in multiple molecular forms in human liver and brain. In Niemann-Pick disease, type C, a deficiency of a specific sphingomyelinase was noted in liver and brain from two patients. The lack of this enzyme probably reflects the genetic defect in this disease.

[1]  M. Halperin,et al.  Control of fatty acid synthesis in white adipose tissue by insulin: coordination between the mitochondrial citrate transporter and pyruvate dehydrogenase. , 1974, Canadian journal of biochemistry.

[2]  M. Halperin,et al.  Regulation of pyruvate dehydrogenase in muscle. Inhibition by citrate. , 1973, The Journal of biological chemistry.

[3]  M. Halperin,et al.  Effects of palmitoyl CoA on citrate and malate transport by rat liver mitochondria. , 1972, Proceedings of the National Academy of Sciences of the United States of America.

[4]  M. Halperin,et al.  The inhibition by methylmalonic acid of malate transport by the dicarboxylate carrier in rat liver mitochondria. A possible explantation for hypoglycemia in methylmalonic aciduria. , 1971, The Journal of clinical investigation.

[5]  G. R. Williams,et al.  Factors affecting the kinetics and equilibrium of exchange reactions of the citrate-transporting system of rat liver mitochondria. , 1971, The Journal of biological chemistry.

[6]  G. R. Williams,et al.  The sensitivity of the exchange reactions of tricarboxylate, 2-oxoglutarate and dicarboxylate transporting systems of rat liver mitochondria to inhibition by 2-pentylmalonate, p-iodobenzylmalonate, and benzene 1,2,3-tricarboxylate. , 1971, European journal of biochemistry.

[7]  G. R. Williams,et al.  The effects of 2-ethylcitrate and tricarballylate on citrate transport in rat liver mitochondria and fatty acid synthesis in rat white adipose tissue. , 1970, European journal of biochemistry.

[8]  J. R. Kuipers,et al.  Propionicacidemia, a New Inborn Error of Metabolism , 1968, Pediatric Research.

[9]  W. Young,et al.  Methylmalonic aciduria. An inborn error of metabolism leading to chronic metabolic acidosis. , 1967, Archives of disease in childhood.

[10]  W. Gruber,et al.  Determination of citrate with citrate lyase. , 1966, Analytical biochemistry.

[11]  John D. Roberts,et al.  The Ionization of Citric Acid Studied by the Nuclear Magnetic Resonance Technique , 1960 .

[12]  H. Moser,et al.  Branched-chain and odd-numbered fatty acids and aldehydes in the nervous system of a patient with deranged vitamin B 12 metabolism. , 1973, Journal of lipid research.

[13]  W. Bortz,et al.  Regulation of fatty acid synthesis at the acetyl-CoA carboxylation step☆ , 1965 .